Discovery of first-in-class imidazothiazole-based potent and selective ErbB4 (HER4) kinase inhibitors
Seyed–Omar Zaraei, Rawan M. Sbenati, Nour N. Alach, Hanan S. Anbar, Randa El‐Gamal, Hamadeh Tarazi, Mahmoud K. Shehata, Mohammed S. Abdel‐Maksoud, Chang‐Hyun Oh, Mohammed I. El–Gamal
Topics & Concepts
ChemistryKinasehERGDocking (animal)IC50Protein kinase AStereochemistryBiochemistryPharmacologyIn vitroBiophysicsBiologyPotassium channelMedicineNursingHER2/EGFR in Cancer ResearchMonoclonal and Polyclonal Antibodies Research14-3-3 protein interactions